{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05219825",
            "orgStudyIdInfo": {
                "id": "8165"
            },
            "organization": {
                "fullName": "New York State Psychiatric Institute",
                "class": "OTHER"
            },
            "briefTitle": "Breathwork-assisted Treatment for Cannabis Use Disorder",
            "officialTitle": "Breathwork-assisted Treatment for Cannabis Use Disorder: A Proof-of-concept Study",
            "therapeuticArea": [
                "Other"
            ],
            "study": "breathwork-assisted-treatment-for-cannabis-use-disorder"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-02-06",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-12-30",
            "studyFirstSubmitQcDate": "2022-02-01",
            "studyFirstPostDateStruct": {
                "date": "2022-02-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-02",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Elias Dakwar",
                "investigatorTitle": "Associate Professor of Clinical Psychiatry",
                "investigatorAffiliation": "New York State Psychiatric Institute"
            },
            "leadSponsor": {
                "name": "Elias Dakwar",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this proof-of-concept study is to evaluate the safety, feasibility and acceptability of a breathwork workshop intervention in individuals with cannabis use disorder.",
            "detailedDescription": "This study will test a 1-week breathwork workshop for treatment-seeking adults with a diagnosis of cannabis use disorder. The intervention consists of an enhanced breathing session with evocative music to facilitate experiencing non-ordinary states of consciousness, in addition to brief therapeutic interventions based on Motivational Interviewing and Mindfulness-based Relapse Prevention (MBRP). The primary aim is to test the acceptability, feasibility and safety of enhanced breathwork in a therapeutic framework for cannabis use disorder. In addition, the investigators seek to understand the phenomenology of breathwork that may explain any change related to addictive behaviors, as well as biological changes that occur during the breathwork session through heart rate variability and electroencephalography."
        },
        "conditionsModule": {
            "conditions": [
                "Addiction",
                "Substance Abuse",
                "Cannabis Use Disorder",
                "Cannabis Use",
                "Cannabis Dependence",
                "Cannabis Abuse"
            ],
            "keywords": [
                "Addiction",
                "cannabis use disorder",
                "Breathwork",
                "Non-ordinary states of consciousness",
                "Non-ordinary experiences",
                "Contemplative practices",
                "Altered states of consciousness",
                "Cannabis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Breathwork group",
                    "type": "EXPERIMENTAL",
                    "description": "Treatment-seeking individuals with cannabis use disorder who will participate in the 1-week breathwork workshop.",
                    "interventionNames": [
                        "Behavioral: Breathwork workshop"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Breathwork workshop",
                    "description": "Participants will complete 1.5 hours of breathwork session in addition to a total of 6 hours of brief psychotherapeutic intervention in a span of 1 week. The therapy sessions will occur both before and after the breathing session.",
                    "armGroupLabels": [
                        "Breathwork group"
                    ],
                    "otherNames": [
                        "Enhanced breathing session + Brief psychotherapeutic intervention"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Acceptability of the breathwork session",
                    "description": "Acceptability of the breathwork intervention through self-reported questionnaires.",
                    "timeFrame": "One week after the breathing session."
                },
                {
                    "measure": "Safety of the breathing session",
                    "description": "Occurrence of adverse effects through a self-reported questionnaire.",
                    "timeFrame": "24 hours after the breathing session."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Cue Reactivity",
                    "description": "Serial visual analogue scale for craving elicited by cannabis use.",
                    "timeFrame": "From baseline to 1 month after the breathing session."
                },
                {
                    "measure": "Change in Motivation to Quit",
                    "description": "Measured with the \"Stages of Change Readiness and Treatment Eagerness Scale.\"",
                    "timeFrame": "From baseline to 1 month after the breathing session."
                },
                {
                    "measure": "Change in cannabis use",
                    "description": "Changes in cannabis use as measured by the Timeline Followback.",
                    "timeFrame": "From baseline to 1 month after the breathing session."
                },
                {
                    "measure": "Phenomenology of breathwork #1",
                    "description": "Subjective experiences during the breathing session will be assessed with the 30-item Mystical Experience Questionnaire.",
                    "timeFrame": "24 hours after the breathing session"
                },
                {
                    "measure": "Phenomenology of breathwork #2",
                    "description": "Subjective experiences during the breathing session will be assessed with the Emotional Breakthrough Inventory.",
                    "timeFrame": "Obtained 24 hours after the breathing session"
                },
                {
                    "measure": "Heart Rate Variability",
                    "description": "Polar (H10) chest strap",
                    "timeFrame": "Measured during breathing session"
                },
                {
                    "measure": "Electroencephalographic changes",
                    "description": "Electroencephalograpy cap",
                    "timeFrame": "Measured during breathing session"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 18-70 years of age\n* Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for active cannabis use disorder.\n* Seeking treatment for their cannabis use\n\nExclusion Criteria:\n\n* Meets DSM-V criteria for schizophrenia or any psychotic illness or any dissociative disorder (Dissociative identity disorder, Dissociative amnesia, Depersonalization/derealization disorder).\n* Active substance use disorder except for cannabis, nicotine, and caffeine.\n* History of severe withdrawal symptoms (i.e withdrawal seizures).\n* History of dementia, epilepsy or seizures, cardiac arrhythmia, pacemaker/defibrillator, heart failure, asthma, panic disorder and other respiratory illnesses (ie: COPD).",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Danielle Mayall, B.A",
                    "role": "CONTACT",
                    "phone": "(888) 497-8427",
                    "email": "danielle.mayall@nyspi.columbia.edu"
                },
                {
                    "name": "Silvia J Franco Corso, M.D",
                    "role": "CONTACT",
                    "phone": "(914) 481-3820",
                    "email": "silvia.franco-corso@nyspi.columbia.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Silvia J Franco Corso, M.D",
                    "affiliation": "New York State Psychiatric Institute/ Columbia University Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Elias Dakwar, M.D",
                    "affiliation": "New York State Psychiatric Institute/ Columbia University Medical Center",
                    "role": "STUDY_CHAIR"
                },
                {
                    "name": "Kate O'Malley, M.A",
                    "affiliation": "New York State Psychiatric Institute/ Columbia University",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "New York State Psychiatric Institute",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Silvia Franco Corso, M.D.",
                            "role": "CONTACT",
                            "email": "silvia.franco-corso@nyspi.columbia.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002189",
                    "term": "Marijuana Abuse"
                },
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000016739",
                    "term": "Behavior, Addictive"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003192",
                    "term": "Compulsive Behavior"
                },
                {
                    "id": "D000007175",
                    "term": "Impulsive Behavior"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5449",
                    "name": "Marijuana Abuse",
                    "asFound": "Cannabis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19100",
                    "name": "Behavior, Addictive",
                    "asFound": "Addiction",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "asFound": "Substance Abuse",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6418",
                    "name": "Compulsive Behavior",
                    "relevance": "LOW"
                },
                {
                    "id": "M10220",
                    "name": "Impulsive Behavior",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "asFound": "All-Trans Retinoic Acid",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}